Statement: The content of this Q&A reflects the current views of CQAF, for mutual learning and exchange among industry colleagues.
- 2025-08-01 00:05:26
-
项目进行过程中,为使部分潜在参与者(在签署知情同意书前)符合某临床试验的既往用药或者治疗史,有意调整潜在受试者用药,并在原始记录中对部分药物描述疗效不佳或受试者不耐受,这种情况是否可以接受,如何考虑?
- 2025-08-01 00:04:52
- 2025-08-01 00:04:33
- 2025-08-01 00:04:17
- 2025-08-01 00:03:53